InvestorsHub Logo
Followers 1
Posts 210
Boards Moderated 0
Alias Born 01/24/2020

Re: None

Monday, 05/03/2021 3:41:30 PM

Monday, May 03, 2021 3:41:30 PM

Post# of 1668
Sent the following email to PROF investor relations and copied CEO and ACFO:

Steve,

I have been seeing ads on TV quite often for a new product for BPH which competes with Tulsa Pro. Here is the website for the product:

https://www.urolift.com/

I have been a stockholder for a couple years now and in my opinion Tulsa Pro is a superior solution for BPH and of course also for many prostate cancers. The ads I see are well done and proclaim the procedure is incision free. They show water dripping from a pipe and then a fire hose....I think you can get the message and it would be appealing to someone with BPH. This company is stealing our potential customers who likely don't know about Tulsa Pro and also very likely their urologist doesn't know about it either. They are going to be asking their urologist about urolift, not Tulsa Pro simply because they don't know about Tulsa Pro.

Can you bring this to the attention of management? The adoption of Tulsa Pro seems to be going slower than expected based on the number of installations however I note where it is installed the number of procedures being done exceeds expectations. This tells me the doctors and patients who know about Tulsa Pro and are using it like it and prefer it to other solutions.

I think this says loudly that Profound needs to get the word out to the public on this procedure. An ad campaign is what I am thinking. We can make the same claim that it is incision free and likely other claims. I'm guessing the urolift may eliminate or make difficult other future procedures that may need to be done on a patient because it looks like it embeds a medical device which I'm guessing is metallic although I have not researched it.

Thank you,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PROF News